AI-poweredspatial biomarkers
Ground Truth Labs AI platform quantifies complex spatial biomarkers from images of routine histopathology slides, guiding drug development, de-risking clinical trials and advancing clinical diagnosis.
Current methods are limited
- Analysis variability: Subjectivity causes inconsistencies across samples and timepoints. The use of categorical grading systems to combat this strip away nuanced details, critical for accurate analysis.
- Slow turnaround times: Traditional methods often require batching and can cause delays, leading to increased study durations and cost overruns.
- Limited tissue samples: The need for larger samples can limit the scope of tests, potentially affecting the depth of the trial's analysis.
AI-powered spatial biomarkers overcome traditional limitations and enhance trial decisions
Robust subtyping
Objective comparisons between patients, cohorts, and treatments.
Fast quantitation
![Heatmap biomaker quantitation](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Ftissue-heatmap.f2750521.webp&w=3840&q=75)
Transforming traditional grading with robust, spatial metrics in near real-time.
Deep insights
Measure therapeutic response against a backdrop of morphological disease variation.
All from standard slides
Get more from your existing data and workflows — no special staining or obscure data requirements.
Boost your research,
start using AI biomarkers today
We're applying our technology to trials, research, and clinical audits today.
Get in touch